-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
ML324
Category | Cytomegalovirus (CMV) |
CAS | 1222800-79-4 |
Description | ML324 exhibits good Caco-2 cell permeability, and possesses excellent microsomal stability in the presence of both mouse and rat liver microsomes. |
Product Information
Synonyms | ML-324; ML 324; ML324; CID-44143209; CID 44143209; CID44143209. |
IUPAC Name | N-[3-(dimethylamino)propyl]-4-(8-hydroxyquinolin-6-yl)benzamide |
Molecular Weight | 349.43 |
Molecular Formula | C21H23N3O2 |
Canonical SMILES | CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC(=C3C(=C2)C=CC=N3)O |
InChI | InChI=1S/C21H23N3O2/c1-24(2)12-4-11-23-21(26)16-8-6-15(7-9-16)18-13-17-5-3-10-22-20(17)19(25)14-18/h3,5-10,13-14,25H,4,11-12H2,1-2H3,(H,23,26) |
InChIKey | QDBVSOZTVKXUES-UHFFFAOYSA-N |
Boiling Point | 590.1±50.0 °C at 760 mmHg |
Flash Point | 310.7±30.1 °C |
Purity | >98% |
Density | 1.2±0.1 g/cm3 |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Yellow to gray (Solid) |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 449 |
Exact Mass | 349.17902698 |
Index Of Refraction | 1.629 |
In Vitro | ML324 produces a significant reduction in Aa-LPS-induced osteoclastogenesis in osteoclast progenitors |
Target | IC50: JMJD2, 4.9 μM (KDM4B) |
Vapor Pressure | 0.0±1.7 mmHg at 25°C |
XLogP3-AA | 3.1 |